A genome-wide Association study of the Count of Codeine prescriptions

A genome-wide Association study of the Count of Codeine prescriptions

Abstract Opioid prescription records in existing electronic health record (EHR) databases are a potentially useful, high-fidelity data source for opioid use-related risk phenotyping in genetic analyses. Prescriptions for codeine derived from EHR records were used as targeting traits by screening 16 ...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Wenyu Song, Max Lam, Ruize Liu, Aurélien Simona, Scott G. Weiner, Richard D. Urman, Kenneth J. Mukamal, Adam Wright, David W. Bates
Format:	Artykuł
Język:	English
Wydane:	Nature Portfolio 2024-10-01
Seria:	Scientific Reports
Hasła przedmiotowe:	Medication use phenotype Electronic health record Genome-wide association study Opioid use disorder Polygenic risk score Opioid prescription phenotype
Dostęp online:	https://doi.org/10.1038/s41598-024-73925-4

Podobne zapisy

Prescription opioid use in Israel – the tide has risen, but it’s not a tidal wave
od: Yehuda Neumark, i wsp.
Wydane: (2024-10-01)

Predictors of chronic prescription opioid use after orthopedic surgery: derivation of a clinical prediction rule.
od: Daniel I Rhon, i wsp.
Wydane: (2018-11-01)

Associations between spouse and service member prescriptions for high-risk and long-term opioids: A dyadic study
od: Alicia C. Sparks, i wsp.
Wydane: (2021-12-01)

Prescription History of Emergency Department Patients Prescribed Opioids
od: Jason A Hoppe, i wsp.
Wydane: (2013-05-01)

Prevalence and Profile of Tapentadol Use in Patients Visiting a Drug De-addiction Center in Kashmir
od: Syed Mehvish, i wsp.
Wydane: (2024-11-01)

Receipt of prescription opioid medication is associated with increased mortality in an Israeli population
od: Matan J. Cohen, i wsp.
Wydane: (2024-04-01)

Treatment Outcomes in Patients With Opioid Use Disorder Who Were First Introduced to Opioids by Prescription: A Systematic Review and Meta-Analysis
od: Nitika Sanger, i wsp.
Wydane: (2020-08-01)

Trends in Israeli community-based opioid prescribing, 2010–2020, an observational study of the country’s largest HMO
od: Reuven L. Dressler, i wsp.
Wydane: (2023-11-01)

WAYS TO OPTIMIZE THE SYSTEM OF REALIZATION OPIOID ANALGESICS BY PRESCRIPTION THROUGH PHARMACIES
od: N.O. Datsiuk, i wsp.
Wydane: (2016-09-01)

Adverse outcomes associated with opioid prescription for acute low back pain: a systematic review protocol
od: Natalia Mouravska, i wsp.
Wydane: (2017-08-01)

Targeting the Orexin System for Prescription Opioid Use Disorder
od: Alessandra Matzeu, i wsp.
Wydane: (2020-04-01)

Opioid Poisoning and Opioid Use Disorder in Older Trauma Patients
od: Daoust R, i wsp.
Wydane: (2020-05-01)

Knowledge, experiences, and perceptions of medications for opioid use disorder among Black Kentuckians
od: Paris B. Wheeler, i wsp.
Wydane: (2024-12-01)

Today’s nonmedical opioid users are not yesterday’s patients; implications of data indicating stable rates of nonmedical use and pain reliever use disorder
od: Singer JA, i wsp.
Wydane: (2019-02-01)

Prescription drugs with potential for misuse in Irish prisons: analysis of national prison prescribing trends, by gender and history of opioid use disorder, 2012 to 2020
od: Louise Durand, i wsp.
Wydane: (2023-10-01)

Exploring the use of cannabis as a substitute for prescription drugs in a convenience sample
od: Sinikka L. Kvamme, i wsp.
Wydane: (2021-07-01)

Pain management, prescription opioid mortality, and the CDC: is the devil in the data?
od: Schatman ME, i wsp.
Wydane: (2017-10-01)

The prescription drug monitoring program in a multifactorial approach to the opioid crisis: PDMP data, Pennsylvania, 2016–2020
od: Jenna R. Adalbert, i wsp.
Wydane: (2023-04-01)

Prescription drug dependence with and without concurrent illicit drug use: a multicenter cross-sectional survey among an addiction treatment seeking population
od: Asma Nawaz, i wsp.
Wydane: (2023-06-01)

Changing the default option in electronic medical records reduced postoperative opioid prescriptions after cardiac surgeryCentral MessagePerspective
od: Arnar Einarsson, BS, i wsp.
Wydane: (2021-12-01)

Using prescribing and toxicology data to determine non-medical prescription drug overdose
od: Philip Huynh, i wsp.
Wydane: (2020-12-01)

Prescription stimulant use during long-term opioid therapy and risk for opioid use disorder
od: Jeffrey F. Scherrer, i wsp.
Wydane: (2022-12-01)

Acute poisoning related to the recreational use of prescription drugs: an observational study from Oslo, Norway
od: Marit Mæhle Grimsrud, i wsp.
Wydane: (2019-10-01)

The effects of opioid policy changes on transitions from prescription opioids to heroin, fentanyl and injection drug use: a qualitative analysis
od: Julia Dickson-Gomez, i wsp.
Wydane: (2022-07-01)

Cost savings from averted prescription opioidattributable dental diseases in the United States between 2013 and 2019
od: Daniel Erim, i wsp.
Wydane: (2021-05-01)

Correlations between opioid mortality increases related to illicit/synthetic opioids and reductions of medical opioid dispensing - exploratory analyses from Canada
od: Benedikt Fischer, i wsp.
Wydane: (2020-01-01)

Contextualizing prescription opioid misuse and heroin use within dimensional models of drug involvement
od: Genevieve F. Dash, i wsp.
Wydane: (2022-12-01)

Publicly available machine learning models for identifying opioid misuse from the clinical notes of hospitalized patients
od: Brihat Sharma, i wsp.
Wydane: (2020-04-01)

External validation of an opioid misuse machine learning classifier in hospitalized adult patients
od: Majid Afshar, i wsp.
Wydane: (2021-03-01)

Assessing the prevalence of non-medical prescription opioid use in the Canadian general adult population: evidence of large variation depending on survey questions used
od: Shield Kevin D, i wsp.
Wydane: (2013-01-01)

Effect of State Legislation on Discharge Opioid Prescriptions After Total Hip and Knee Arthroplasties
od: Charles P. Benfield, MD, i wsp.
Wydane: (2020-12-01)

Prescription Opioid Usage and Abuse Relationships: An Evaluation of State Prescription Drug Monitoring Program Efficacy
od: Richard M. Reisman, i wsp.
Wydane: (2009-01-01)

Prescription opioid dispensing and prescription opioid poisoning: Population data from Victoria, Australia 2006 to 2013
od: Janneke Berecki‐Gisolf, i wsp.
Wydane: (2017-02-01)

Opioid‐limiting legislation and prescribing habits of otolaryngologists among Medicare beneficiaries
od: Yun Ji Kim, i wsp.
Wydane: (2023-08-01)

Opioid prescription patterns among radiation oncologists in the United States
od: Tina Q. Huang, i wsp.
Wydane: (2020-05-01)

Non-medical prescription opioid use among high school students in 38 U.S. States
od: Himani Byregowda, i wsp.
Wydane: (2023-06-01)

Cost-effective interventions to prevent prescription drug misuse: a systematic review
od: L. Yesenia Rodríguez-Tanta, i wsp.
Wydane: (2025-03-01)

Rates of buprenorphine prescribing and racial disparities among patients with opioid overdose
od: Kimberly Y. Chieh, i wsp.
Wydane: (2024-12-01)

Mortality by opioid poisoning in children and teenagers and opioid prescriptions
od: Elise Cranfield, i wsp.
Wydane: (2021-12-01)

Naloxone prescription fills and use by patients treated for opioid use disorder by telehealth
od: Scott G. Weiner, i wsp.
Wydane: (2024-06-01)